Zhejiang HISUN Biomaterials Co. Ltd. A (688203) — Capital Reinvestment Ratio
Zhejiang HISUN Biomaterials Co. Ltd. A (688203) has a Capital Reinvestment Ratio of 7.55x as of December 2024, meaning it reinvests 8% of its operating cash flow (CN¥38.84 Million) in capital expenditures (CN¥293.18 Million). See cash generation quality of Zhejiang HISUN Biomaterials Co. Ltd. A to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang HISUN Biomaterials Co. Ltd. A Capital Reinvestment Ratio (2020–2024)
This chart tracks Zhejiang HISUN Biomaterials Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Zhejiang HISUN Biomaterials Co. Ltd. A (2020–2024)
Year-by-year Capital Reinvestment Ratio for Zhejiang HISUN Biomaterials Co. Ltd. A from 2020 to 2024. For live market cap and broader valuation context, see how much is Zhejiang HISUN Biomaterials Co. Ltd. A worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 7.55x | CN¥38.84 Million | CN¥293.18 Million | ▲ +474.8% |
| 2023 | 1.31x | CN¥163.03 Million | CN¥214.11 Million | ▼ -20.6% |
| 2022 | 1.65x | CN¥136.15 Million | CN¥225.27 Million | ▼ -61.9% |
| 2021 | 4.35x | CN¥71.18 Million | CN¥309.44 Million | ▼ -37.1% |
| 2020 | 6.91x | CN¥28.66 Million | CN¥198.08 Million | — |